These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
574 related items for PubMed ID: 18703366
1. Stability of blood phenylalanine levels and IQ in children with phenylketonuria. Anastasoaie V, Kurzius L, Forbes P, Waisbren S. Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366 [Abstract] [Full Text] [Related]
2. Neurocognitive functioning in adults with phenylketonuria: results of a long term study. Weglage J, Fromm J, van Teeffelen-Heithoff A, Möller HE, Koletzko B, Marquardt T, Rutsch F, Feldmann R. Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437 [Abstract] [Full Text] [Related]
3. Children and adolescents with phenylketonuria display fluctuations in their blood phenylalanine levels. Feldmann R, Schallert M, Nguyen T, Och U, Rutsch F, Weglage J. Acta Paediatr; 2019 Mar; 108(3):541-543. PubMed ID: 30047169 [Abstract] [Full Text] [Related]
4. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Diamond A, Prevor MB, Callender G, Druin DP. Monogr Soc Res Child Dev; 1997 Mar; 62(4):i-v, 1-208. PubMed ID: 9421921 [Abstract] [Full Text] [Related]
5. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome. Güttler F, Azen C, Guldberg P, Romstad A, Hanley WB, Levy HL, Matalon R, Rouse BM, Trefz F, de la Cruz F, Koch R. Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659 [Abstract] [Full Text] [Related]
6. Variability in phenylalanine control predicts IQ and executive abilities in children with phenylketonuria. Hood A, Grange DK, Christ SE, Steiner R, White DA. Mol Genet Metab; 2014 Apr; 111(4):445-51. PubMed ID: 24568837 [Abstract] [Full Text] [Related]
7. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study. Jahja R, Huijbregts SC, de Sonneville LM, van der Meere JJ, Bosch AM, Hollak CE, Rubio-Gozalbo ME, Brouwers MC, Hofstede FC, de Vries MC, Janssen MC, van der Ploeg AT, Langendonk JG, van Spronsen FJ. Mol Genet Metab; 2013 Apr; 110 Suppl():S57-61. PubMed ID: 24183792 [Abstract] [Full Text] [Related]
8. Sapropterin therapy increases stability of blood phenylalanine levels in patients with BH4-responsive phenylketonuria (PKU). Burton BK, Bausell H, Katz R, Laduca H, Sullivan C. Mol Genet Metab; 2010 Apr; 101(2-3):110-4. PubMed ID: 20638313 [Abstract] [Full Text] [Related]
9. Long-term outcomes of blood phenylalanine concentrations in children with classical phenylketonuria. Hartnett C, Salvarinova-Zivkovic R, Yap-Todos E, Cheng B, Giezen A, Horvath G, Lillquist Y, Vallance H, Stockler-Ipsiroglu S. Mol Genet Metab; 2013 Apr; 108(4):255-8. PubMed ID: 23465864 [Abstract] [Full Text] [Related]
10. Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria. Huijbregts S, de Sonneville L, Licht R, Sergeant J, van Spronsen F. Dev Neuropsychol; 2002 Apr; 22(2):481-99. PubMed ID: 12537335 [Abstract] [Full Text] [Related]
11. Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis. Waisbren SE, Noel K, Fahrbach K, Cella C, Frame D, Dorenbaum A, Levy H. Mol Genet Metab; 2007 Apr; 92(1-2):63-70. PubMed ID: 17591452 [Abstract] [Full Text] [Related]
12. Depression, anxiety, and stress in young adults with phenylketonuria: associations with biochemistry. Clacy A, Sharman R, McGill J. J Dev Behav Pediatr; 2014 Apr; 35(6):388-91. PubMed ID: 25007061 [Abstract] [Full Text] [Related]
13. Children and Adolescents with Early Treated Phenylketonuria: Cognitive Development and Fluctuations of Blood Phenylalanine Levels. Feldmann R, Och U, Beckmann LS, Weglage J, Rutsch F. Int J Environ Res Public Health; 2024 Apr 02; 21(4):. PubMed ID: 38673342 [Abstract] [Full Text] [Related]
14. Event-related potential correlates of selective processing in early- and continuously-treated children with phenylketonuria: effects of concurrent phenylalanine level and dietary control. de Sonneville LM, Huijbregts SC, van Spronsen FJ, Verkerk PH, Sergeant JA, Licht R. Mol Genet Metab; 2010 Apr 02; 99 Suppl 1():S10-7. PubMed ID: 20123462 [Abstract] [Full Text] [Related]
15. Executive functioning in children and adolescents with phenylketonuria. VanZutphen K, Packman W, Sporri L, Needham M, Morgan C, Weisiger K, Packman S. Clin Genet; 2007 Jul 02; 72(1):13-8. PubMed ID: 17594394 [Abstract] [Full Text] [Related]
16. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria. Trefz FK, Blau N. Pediatrics; 2003 Dec 02; 112(6 Pt 2):1566-9. PubMed ID: 14654666 [Abstract] [Full Text] [Related]
17. Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018: Is It a Changing Landscape? Pinto A, Ahring K, Almeida MF, Ashmore C, Bélanger-Quintana A, Burlina A, Coşkun T, Daly A, van Dam E, Dursun A, Evans S, Feillet F, Giżewska M, Gökmen-Özel H, Hickson M, Hoekstra Y, Ilgaz F, Jackson R, Leśniak A, Loro C, Malicka K, Patalan M, Rocha JC, Sivri S, Rodenburg I, van Spronsen F, Strączek K, Tokatli A, MacDonald A. Nutrients; 2024 Jun 28; 16(13):. PubMed ID: 38999811 [Abstract] [Full Text] [Related]
18. Prolonged exposure to high and variable phenylalanine levels over the lifetime predicts brain white matter integrity in children with phenylketonuria. Hood A, Antenor-Dorsey JA, Rutlin J, Hershey T, Shimony JS, McKinstry RC, Grange DK, Christ SE, Steiner R, White DA. Mol Genet Metab; 2015 Jan 28; 114(1):19-24. PubMed ID: 25481106 [Abstract] [Full Text] [Related]
19. Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level. Schmidt E, Rupp A, Burgard P, Pietz J, Weglage J, de Sonneville L. J Clin Exp Neuropsychol; 1994 Oct 28; 16(5):681-8. PubMed ID: 7836491 [Abstract] [Full Text] [Related]